YU69503A - Kombinacija taksana i ciklin-zavisne kinaze - Google Patents

Kombinacija taksana i ciklin-zavisne kinaze

Info

Publication number
YU69503A
YU69503A YU69503A YUP69503A YU69503A YU 69503 A YU69503 A YU 69503A YU 69503 A YU69503 A YU 69503A YU P69503 A YUP69503 A YU P69503A YU 69503 A YU69503 A YU 69503A
Authority
YU
Yugoslavia
Prior art keywords
cyclin
dependent kinase
taxane
combination
kinase inhibitor
Prior art date
Application number
YU69503A
Other languages
English (en)
Inventor
Marie-Christine Bissery
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of YU69503A publication Critical patent/YU69503A/sh
Publication of RS50681B publication Critical patent/RS50681B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Opisana je farmaceutska kompozicija koja uključuje TaxolВ®, TaxotereВ® ili derivate i ciklin-zavisnu kinazu, kao i način primene, pri čemu se taksan daje naizmenično, a ciklin-zavisna kinaza se daje sa ponavljanjem u okviru istog ciklusa.[A pharmaceutical composition comprised of TaxolВ®, TaxotereВ®, or derivatives and a cyclin-dependent kinase is described, as well as a form of administration wherein the taxane is given intermittently and the cyclin-dependent kinase is given repeatedly within the same cycle.
YUP-695/03A 2001-03-23 2002-03-22 Kombinacija taksana i ciklin-zavisne kinaze RS50681B (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27794801P 2001-03-23 2001-03-23
US30269201P 2001-07-05 2001-07-05
US33491601P 2001-12-04 2001-12-04

Publications (2)

Publication Number Publication Date
YU69503A true YU69503A (sh) 2006-08-17
RS50681B RS50681B (sr) 2010-06-30

Family

ID=27402954

Country Status (33)

Country Link
US (2) US20020182204A1 (sh)
EP (1) EP1372652B1 (sh)
JP (1) JP2004521140A (sh)
KR (1) KR100879712B1 (sh)
CN (1) CN1498107A (sh)
AR (1) AR034222A1 (sh)
AT (1) ATE395917T1 (sh)
AU (1) AU2002312815B2 (sh)
BR (1) BR0208221A (sh)
CA (1) CA2441441C (sh)
CY (1) CY1110449T1 (sh)
CZ (1) CZ301423B6 (sh)
DE (1) DE60226710D1 (sh)
DK (1) DK1372652T3 (sh)
EA (1) EA007815B1 (sh)
ES (1) ES2305253T3 (sh)
HR (1) HRPK20030766B3 (sh)
HU (1) HU229258B1 (sh)
IL (2) IL158058A0 (sh)
ME (1) MEP16408A (sh)
MX (1) MXPA03007743A (sh)
NO (1) NO332441B1 (sh)
NZ (1) NZ527655A (sh)
PE (1) PE20020907A1 (sh)
PL (1) PL206118B1 (sh)
PT (1) PT1372652E (sh)
RS (1) RS50681B (sh)
SI (1) SI1372652T1 (sh)
SK (1) SK287481B6 (sh)
TW (1) TWI355935B (sh)
UY (1) UY27220A1 (sh)
WO (1) WO2002076484A2 (sh)
ZA (1) ZA200307381B (sh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1487434B1 (en) * 2002-03-06 2007-05-09 The Medical Research and Education Trust Botanical extract compositions with anti-cancer activity comprising isoliquiritigenin
WO2004035034A2 (en) * 2002-10-16 2004-04-29 Ilex Products, Inc. Clofarabine and taxane chemotherapy combination
DE60325502D1 (de) * 2002-11-06 2009-02-05 Cyclacel Ltd Kombination aus docetaxel und einem cdk-hemmer
EA014231B1 (ru) * 2006-02-10 2010-10-29 НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. Комбинации, включающие ингибитор cdk и антитело фактора роста или антимитотик
US20130237582A1 (en) * 2010-11-19 2013-09-12 Piramal Enterprises Limited Pharmaceutical combination of paclitaxel and a cdk inhibitor
AU2012235902B2 (en) * 2011-04-01 2015-08-27 Astrazeneca Ab Therapeutic treatment
FI2785349T4 (fi) 2011-11-30 2023-02-09 Syövän yhdistelmähoito
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
AU2195297A (en) * 1996-02-20 1997-09-02 Sloan-Kettering Institute For Cancer Research Combinations of pkc inhibitors and therapeutic agents for treating cancers

Also Published As

Publication number Publication date
US20060128640A1 (en) 2006-06-15
SI1372652T1 (sl) 2008-10-31
NO332441B1 (no) 2012-09-17
EA200301053A1 (ru) 2004-02-26
HUP0303589A2 (hu) 2004-03-01
IL158058A0 (en) 2004-03-28
WO2002076484A3 (en) 2003-01-03
MEP16408A (en) 2010-10-10
CZ20032551A3 (en) 2004-07-14
UY27220A1 (es) 2002-09-30
MXPA03007743A (es) 2004-11-12
CY1110449T1 (el) 2015-04-29
HRP20030766A2 (en) 2005-06-30
AU2002312815B2 (en) 2006-08-24
CA2441441A1 (en) 2002-10-03
HRPK20030766B3 (en) 2006-11-30
KR20030086318A (ko) 2003-11-07
TWI355935B (en) 2012-01-11
JP2004521140A (ja) 2004-07-15
IL158058A (en) 2010-02-17
NO20034124D0 (no) 2003-09-16
PE20020907A1 (es) 2002-12-19
PT1372652E (pt) 2008-07-24
CZ301423B6 (cs) 2010-02-24
SK287481B6 (sk) 2010-11-08
PL206118B1 (pl) 2010-07-30
HU229258B1 (en) 2013-10-28
US20020182204A1 (en) 2002-12-05
ES2305253T3 (es) 2008-11-01
AR034222A1 (es) 2004-02-04
CA2441441C (en) 2009-05-26
EP1372652A2 (en) 2004-01-02
RS50681B (sr) 2010-06-30
EP1372652B1 (en) 2008-05-21
PL367702A1 (en) 2005-03-07
ZA200307381B (en) 2005-03-30
KR100879712B1 (ko) 2009-01-22
CN1498107A (zh) 2004-05-19
HUP0303589A3 (en) 2007-05-02
ATE395917T1 (de) 2008-06-15
DK1372652T3 (da) 2008-09-22
NO20034124L (no) 2003-09-16
SK11692003A3 (sk) 2004-03-02
NZ527655A (en) 2006-03-31
WO2002076484A2 (en) 2002-10-03
DE60226710D1 (de) 2008-07-03
BR0208221A (pt) 2004-03-02
EA007815B1 (ru) 2007-02-27

Similar Documents

Publication Publication Date Title
MXPA03010134A (es) Derivados de ciclohexan-1-4-diamina sustituidos.
MXPA03008045A (es) Nuevas composiciones de medicamentos en base a agentes anticolinergicos e inhibidores de pde-iv.
PL412704A1 (pl) Pochodne fosfonooksychinazoliny, ich kompozycje farmaceutyczne oraz ich zastosowanie
MY141739A (en) Substituted quinazoline derivatives as inhibitors of aurora kinases
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
PL366622A1 (en) Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
HUP0400194A3 (en) Imidazolidindion derivatives as metalloproteinase inhibitors, their use and pharmaceutical compositions containing them
NZ514409A (en) C7 ester substituted taxanes as antitumor agents
PL372809A1 (en) Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
HN2002000300A (es) Nuevos derivados de piperazina
NO20051187L (no) Depotformuleringer bestaende av aktive arylheterocykliske forbindelser i form av en suspensjon
NO20042739L (no) Farmasoytiske sammensetninger av 5,6,14-triazatetracyklo(10.3.1.0(2,11).0(4,9))-heksadeca-2(11)3,5,7,9-pentan
IL173810A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
IL158898A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING APOMORPHINE, 6aR-(-)-N-PROPYL-NORAPOMORPHINE AND DERIVATIVES THEREOF
WO2002008217A3 (en) COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS
MXPA03006538A (es) Nuevos derivados de urea, su procedimiento de preparacion, su aplicacion como medicamentos, composiciones farmaceuticas y nueva utilizacion.
ATE320256T1 (de) Succinate des 5,8,14-triazatetracyclo(10.3.1.0 2, 11 .0 4,9 )-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
CY1110449T1 (el) Συνδυασμος δοκεταξελης και φλαβοπιριδinολης
IL173895A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
MY134026A (en) ?-carboline derivatives and its pharmaceutical use against depression and anxiety
DE60121804D1 (de) Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
IL157870A0 (en) Piperazino derivatives and pharmaceutical compositions containing the same
ATE241376T1 (de) Zusammensetzungen, die dolastatin-15-analoge in kombination mit taxane und dessen derivaten enthalten